These side effects have led to a slew of litigation, from patient lawsuits to. But like any other drug, Risperdal has side effects, including causing breast enlargement and diminished sexual functioning in young autistic boys. Food and Drug Administration approved Risperdal in 1993 to treat schizophrenia and bipolar mania in adults, but it was only in 2006 that its use was approved for irritability associated with autism in children. Like few other drugs, the antipsychotic Risperdal can treat schizophrenia and bipolar disorder, and reduce irritability and aggressive behavior in autistic children. Consumer Medicine Information (CMI) about Risperdal Tablets and Solution (Risperidone) intended for persons.
The lawsuits generally accused J&J of failing to warn of the risk of a condition called gynecomastia associated with Risperdal, which they said the company marketed for off-label, unapproved uses with children. Lawyers for plaintiffs did not immediately respond to requests for comment. Many of the lawsuits were also pending in Pennsylvania, and the company also faced cases in California and Missouri. It was unclear what other cases in the United States were part of the accord.
J&J said it accrued $800 million in legal expenses in the third quarter related to the settlement. The company said it reached the agreement with lawyers handling cases including a lawsuit in state court in Philadelphia by Nicholas Murray, a Maryland resident who a jury awarded an $8 billion punitive damage award in 2019 that a judge later reduced to $6.8 million. Recent Victories for Risperdal Victims Should Encourage More to Take Action JanuBy US Recall News Leave a Comment After several recent verdicts against Risperdal maker Johnson & Johnson (J&J), the future looks very promising for the roughly 1,600 cases that are still pending against the company in Philadelphia.
0 kommentar(er)
